Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-03-28 Sale | 2024-04-01 9:30 pm | Repare Therapeutics Inc. | RPTX | Forte Steve EVP, CHIEF FINANCIAL OFFICER | 1,614 | $4.6151 | $7,449 | 44,775 (Direct) | View |
2024-03-25 Sale | 2024-03-27 6:59 pm | Repare Therapeutics Inc. | RPTX | Forte Steve EVP, CHIEF FINANCIAL OFFICER | 2,475 | $4.67 | $11,558 | 42,212 (Direct) | View |
2020-06-23 Purchase | 2020-06-25 5:59 pm | Repare Therapeutics Inc. | RPTX | Forte Steve EVP, Chief Financial Officer | 5,000 | $20 | $100,000 | 5,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-03-01 Option Award | 2024-03-05 4:15 pm | N/A 2034-02-28 | Repare Therapeutics Inc. | RPTX | Forte Steve EVP, CHIEF FINANCIAL OFFICER | 99,000 | $0 | 129,687 (Direct) | View |
2023-01-30 Option Award | 2023-02-01 9:44 pm | N/A 2033-01-29 | Repare Therapeutics Inc. | RPTX | Forte Steve EVP, Chief Financial Officer | 135,580 | $0 | 141,737 (Direct) | View |
2022-01-18 Exercise | 2022-01-20 4:45 pm | N/A 2032-01-17 | Repare Therapeutics Inc. | RPTX | Forte Steve EVP, Chief Financial Officer | 100,000 | $0 | 100,000 (Direct) | View |
2021-02-08 Option Award | 2021-02-10 9:07 pm | N/A 2031-02-08 | Repare Therapeutics Inc. | RPTX | Forte Steve EVP, Chief Financial Officer | 71,000 | $0 | 71,000 (Direct) | View |
2020-06-18 Option Award | 2020-06-19 08:04 am | N/A 2030-06-18 | Repare Therapeutics Inc. | RPTX | Forte Steve EVP, Chief Financial Officer | 41,240 | $0 | 41,240 (Direct) | View |
Ownership | 2020-06-18 9:28 pm | N/A 2029-10-28 | Repare Therapeutics Inc. | RPTX | Forte Steve EVP, Chief Financial Officer | 0 | $0 | 325,800 (Direct) | View |